From: Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia
Variables | Median (mean±SD) | P value | |
---|---|---|---|
Pre | Post | ||
Q1 | 1 (1.9 ± 2.0) | 1 (1.6 ± 1.7) | 0.631 |
Q2 | 3 (2.8 ± 1.4) | 2 (2.3 ± 1.3) | 0.263 |
Q3 | 1 (1.9 ± 2.1) | 1 (1.3 ± 1.3) | 0.603 |
Q4 | 2 (1.8 ± 1.6) | 1 (1.6 ± 1.5) | 0.227 |
Q5 | 1 (1.6 ± 1.6) | 1 (2.2 ± 1.9) | 0.598 |
Q6 | 0 (1.1 ± 1.5) | 1 (1.2 ± 1.6) | 0.756 |
Q7 | 3 (2.9 ± 0.7) | 2 (2.4 ± 1.0) | 0.033* |
total score (Q1-7) | 15 (15.0 ± 7.9) | 11 (12.6 ± 6.0) | 0.142 |
QOL | 5 (4.4 ± 1.5) | 4 (3.8 ± 1.5) | 0.206 |